188 related articles for article (PubMed ID: 35127742)
1. Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival.
Yu Y; Tang H; Franceschi D; Mujagond P; Acharya A; Deng Y; Lethaus B; Savkovic V; Zimmerer R; Ziebolz D; Li S; Schmalz G
Front Med (Lausanne); 2021; 8():759605. PubMed ID: 35127742
[TBL] [Abstract][Full Text] [Related]
2. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
[TBL] [Abstract][Full Text] [Related]
3. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
Long S; Li M; Liu J; Yang Y; Li G
Aging (Albany NY); 2020 Apr; 12(8):7112-7128. PubMed ID: 32310827
[TBL] [Abstract][Full Text] [Related]
4. Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.
Ling B; Ye G; Zhao Q; Jiang Y; Liang L; Tang Q
Front Mol Biosci; 2020; 7():603701. PubMed ID: 33505988
[No Abstract] [Full Text] [Related]
5. Identification of Novel Immunologic Checkpoint Gene Prognostic Markers for Ovarian Cancer.
Huo X; Zhang X; Li S; Wang S; Sun H; Yang M
J Oncol; 2022; 2022():8570882. PubMed ID: 36157232
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of immune checkpoint molecules in breast cancer.
Fang J; Chen F; Liu D; Gu F; Chen Z; Wang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32602545
[TBL] [Abstract][Full Text] [Related]
8. Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.
Xu D; Liu X; Wang Y; Zhou K; Wu J; Chen JC; Chen C; Chen L; Zheng J
Biomed Pharmacother; 2020 Jun; 126():109903. PubMed ID: 32113055
[TBL] [Abstract][Full Text] [Related]
9.
Chen Z; Chen Q; Li S; Tu S; Chen Q; Wang A
Ann Transl Med; 2022 Feb; 10(3):144. PubMed ID: 35284546
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.
Ma R; Qu X; Che X; Yang B; Li C; Hou K; Guo T; Xiao J; Liu Y
Onco Targets Ther; 2021; 14():3517-3534. PubMed ID: 34103942
[TBL] [Abstract][Full Text] [Related]
11. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response.
Hu FF; Liu CJ; Liu LL; Zhang Q; Guo AY
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32814346
[TBL] [Abstract][Full Text] [Related]
13. VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma.
Jlassi A; Rejaibi R; Manai M; Sahraoui G; Guerfali FZ; Charfi L; Mezlini A; Manai M; Mrad K; Doghri R
Front Oncol; 2024; 14():1352053. PubMed ID: 38634058
[TBL] [Abstract][Full Text] [Related]
14. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
Wang X; Zhang J; Zhou G
J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.
Zhang J; Jin H; Pan S; Han C; Sun Q; Han X
Front Immunol; 2023; 14():1073550. PubMed ID: 36814908
[TBL] [Abstract][Full Text] [Related]
16. The landscape of
de Vos L; Grünwald I; Bawden EG; Dietrich J; Scheckenbach K; Wiek C; Zarbl R; Bootz F; Landsberg J; Dietrich D
Epigenetics; 2020 Nov; 15(11):1195-1212. PubMed ID: 32281488
[TBL] [Abstract][Full Text] [Related]
17. Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer.
Zhou X; Wang Y; Zheng J; Wang S; Liu C; Yao X; Ren Y; Wang X
Front Genet; 2022; 13():990301. PubMed ID: 36276934
[No Abstract] [Full Text] [Related]
18. Canine oral squamous cell carcinoma as a spontaneous, translational model for radiation and immunology research.
Boss MK; Harrison LG; Gold A; Karam SD; Regan DP
Front Oncol; 2022; 12():1033704. PubMed ID: 36698398
[TBL] [Abstract][Full Text] [Related]
19. Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.
Faruki H; Mayhew GM; Serody JS; Hayes DN; Perou CM; Lai-Goldman M
J Thorac Oncol; 2017 Jun; 12(6):943-953. PubMed ID: 28341226
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
Wen J; Mao X; Cheng Q; Liu Z; Liu F
Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]